Profil
Temre Johnson is currently the Head-Investor Relations & Media Contact at Alpine Immune Sciences, Inc. Prior to this role, Mr. Johnson worked as the Director-Investor Relations & Communications at Mirati Therapeutics, Inc. from 2018 to 2022.
Aktive Positionen von Temre Johnson
| Unternehmen | Position | Beginn |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Investor Relations Contact | - |
Ehemalige bekannte Positionen von Temre Johnson
| Unternehmen | Position | Ende |
|---|---|---|
| MIRATI THERAPEUTICS | Investor Relations Contact | 01.06.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
